DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Kapitalo Investimentos Ltda

Kapitalo Investimentos Ltda lowered its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 33.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,995 shares of the company’s stock after selling 1,990 shares during the period. Kapitalo Investimentos Ltda’s holdings in DocuSign were worth $248,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Massmutual Trust Co. FSB ADV raised its position in DocuSign by 5,000.0% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $27,000 after purchasing an additional 500 shares in the last quarter. Mather Group LLC. increased its stake in shares of DocuSign by 4,338.5% during the second quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after buying an additional 564 shares during the period. Register Financial Advisors LLC acquired a new stake in DocuSign in the first quarter valued at approximately $37,000. nVerses Capital LLC purchased a new position in DocuSign in the second quarter worth approximately $48,000. Finally, Quarry LP acquired a new position in DocuSign during the 2nd quarter worth approximately $53,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at DocuSign

In other DocuSign news, Director Daniel D. Springer sold 287,052 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the completion of the sale, the director now directly owns 923,445 shares of the company’s stock, valued at approximately $49,662,872.10. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Daniel D. Springer sold 287,052 shares of DocuSign stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $53.78, for a total value of $15,437,656.56. Following the sale, the director now owns 923,445 shares of the company’s stock, valued at $49,662,872.10. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 7,725 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $54.89, for a total transaction of $424,025.25. Following the transaction, the chief executive officer now owns 109,918 shares in the company, valued at approximately $6,033,399.02. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 418,002 shares of company stock worth $22,471,973 in the last quarter. Company insiders own 1.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on DOCU shares. Bank of America raised their price objective on shares of DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Citigroup raised their price target on DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Robert W. Baird upped their price objective on DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Royal Bank of Canada raised their target price on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research report on Friday, September 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, DocuSign currently has an average rating of “Hold” and a consensus price target of $63.40.

DocuSign Trading Up 3.7 %

DOCU stock opened at $72.60 on Thursday. The company has a market capitalization of $14.86 billion, a P/E ratio of 139.62, a PEG ratio of 7.33 and a beta of 0.92. The business has a 50 day simple moving average of $59.51 and a 200-day simple moving average of $57.06. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $72.64.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.17. The firm had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. DocuSign’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.09 EPS. Research analysts predict that DocuSign, Inc. will post 1.01 EPS for the current fiscal year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.